New generation vs. first generation antipsychotics debate
There has been significant confusion about the relative advantage of new generation antipsychotics over first generation antipsychotics as well as of clinical trials performed to evaluate their efficacy vs. those designed to evaluate their effectiveness. Pragmatic or effectiveness clinical trials li...
| Permalink: | http://skupnikatalog.nsk.hr/Record/nsk.NSK01000744419/Details |
|---|---|
| Matična publikacija: |
Psychiatria Danubina 21 (2009), 4 ; str. 446-452 |
| Glavni autor: | Jakovljević, Miro (-) |
| Vrsta građe: | Članak |
| Jezik: | eng |
| Predmet: | |
| Online pristup: |
http://hrcak.srce.hr/psychiatria-danubina |
| LEADER | 01771caa a2200277 i 4500 | ||
|---|---|---|---|
| 001 | NSK01000744419 | ||
| 003 | HR-ZaNSK | ||
| 005 | 20121107091304.0 | ||
| 007 | ta | ||
| 008 | 100928s2009 ci ||| ||eng | ||
| 035 | |a (HR-ZaNSK)000744419 | ||
| 040 | |a HR-ZaNSK |b hrv |c HR-ZaNSK |e ppiak | ||
| 042 | |a croatica | ||
| 044 | |a ci |c hr | ||
| 080 | |a 615 |2 MRF 1998. | ||
| 080 | |a 616 |2 MRF 1998. | ||
| 100 | 1 | |a Jakovljević, Miro | |
| 245 | 1 | 0 | |a New generation vs. first generation antipsychotics debate : |b pragmatic clinical trials and practice-based evidence / |c Miro Jakovljević. |
| 300 | |b Ilustr. | ||
| 504 | |a Bibliografija: 27 jed | ||
| 520 | |a There has been significant confusion about the relative advantage of new generation antipsychotics over first generation antipsychotics as well as of clinical trials performed to evaluate their efficacy vs. those designed to evaluate their effectiveness. Pragmatic or effectiveness clinical trials like CATIE and CUtLASS sponsored by governments have challenged the current worldview of the greater advantages of new generation over first generation antipsychotics and suggested more clinical applicability of older antipsychotics. Public policy regarding the role and place of modern antipsychotics in schizophrenia treatment is usually guided by the imperfect state of clinical trials and by economic constraints. Personalized medicine in psychiatry is not possible without the availability of enough number of different modern antipsychotics. | ||
| 653 | 0 | |a Antipsihotici |a Shizofrenija |a Personalizirana medicina |a Psihofarmakoterapija | |
| 773 | 0 | |t Psychiatria Danubina |x 0353-5053 |g 21 (2009), 4 ; str. 446-452 | |
| 981 | |b B08/09 |p CRO | ||
| 998 | |a rado100928 |c vol2o121107 | ||
| 856 | 4 | 2 | |u http://hrcak.srce.hr/psychiatria-danubina |